Stay Updated about our 2017 event here
Back for a 7th year, eyeforpharma Oncology Market Access & Pricing Summit brings together all stakeholders, including pharma, insurance companies, patient advocacy groups, and cancer associations to bridge the gap on the differing views of “value”.
Complete speaker line-up - Program for all tracks & sessions – Audience breakdown
Co-chaired by Aetna’s Michael Kolodziej and now in its 7th year, our conference is regarded by many as the most targeted and high-level gathering on commercialization cancer products in the US.
150+ senior executives are now confirmed to attend. Gain actionable insights from leading oncology innovators including:
Executive VP, US Oncology
SVP US Value, Access, & Policy
VP & Global Head of Oncology Commercial
Senior Director & Head of Global Value & Access
National Medical Director
call our sessions essential
said they will likely return again next year
rated the program very well run
“Excellent discussion of the most current and important clinical pharma related issues at the point of patient care.”
Ira Klein, National Medical Director, AETNA
“The topics were diverse, covering the range of patient, payer, diagnostic and innovation demonstration. I truly enjoyed the opportunity to network - a great forum for learning.”
Nikhil Gadre, Associate Director, Bristol-Myers Squibb
“This Summit is a gathering of brilliant minds and cutting edge information related to Oncology…I didn’t want to miss a single presentation!”
Sandra Nichols, Director, HealthCare Service Corporation
eyeforpharma is a registered company in England and Wales - Registered number 09823909. 7-9 Fashion Street, London, E1 6PX, UK.
Website Development by Fruitbowl Media Ltd.